Related Experiment Video
Updated: Sep 28, 2025

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Comorbidities in hereditary angioedema-A population-based cohort study
Linda Sundler Björkman1, Barbro Persson2, David Aronsson1
1Respiratory Medicine & Allergology, Department of Clinical Sciences Lund, Lund University and Skåne University Hospital, Lund, Sweden.
Hereditary angioedema (HAE) patients face higher risks of cardiovascular and autoimmune diseases, but not cancer. Awareness and prevention of these comorbidities are crucial for HAE management.
Area of Science:
- Immunology
- Genetics
- Epidemiology
Background:
- Hereditary angioedema (HAE) is linked to C1 Inhibitor deficiency, causing complement and contact system activation.
- This study investigates the comorbidity risks associated with HAE.
Purpose of the Study:
- To determine the risk of various comorbidities in individuals with HAE.
- To compare HAE patients with a matched general population cohort.
Main Methods:
- A cohort of 239 HAE patients was compared to 2383 controls from Swedish health registers.
- Conditional logistic regression analysis was employed to assess comorbidity risks.
Main Results:
- HAE patients showed increased risks of cardiovascular diseases (1.83), including thromboembolic events (4.20) and hypertension (1.64).
- A higher incidence of hyperlipidemia (2.01) and autoimmune diseases (1.65), particularly systemic lupus erythematosus (71.87), was observed in HAE patients.
- No increased risk of cancer was found in the HAE cohort.
Conclusions:
- HAE patients require heightened awareness and preventive strategies for thromboembolic and autoimmune diseases.
- Future research should explore prophylactic interventions to mitigate these HAE-associated risks.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology